Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 24Motor Activity 14Carcinoma, Non-Small-Cell Lung 11Neoplasms 3Pancreatic Neoplasms 2Gastrointestinal Neoplasms 2Fatigue 2Breast Neoplasms 2Weight Loss 1Vomiting 1Urogenital Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sedentary Behavior 1Rehabilitation After Lung Cancer Surgery 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Nausea 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma 1Lung Cancer Patients 1Inflammation 1Health Education 1Esophageal Neoplasms 1Disease 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1

Interventions

Dexamethasone 3Aprepitant 2Analgesia 2netupitant, palosentron drug combination 1netupitant 1fosaprepitant 1casopitant 1Yoga 1Therapeutics 1Radiotherapy 1Psychiatric Rehabilitation 1Palonosetron 1Ondansetron 1Massage 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Exercise × Thoracic × Clear all
NCT00891761 2015-04-17

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

GlaxoSmithKline

Phase 3 Withdrawn
Thoracic

Lung Neoplasms, Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡